NASDAQ · Healthcare · Biotechnology
Humacyte, Inc.
HUMA
Humacyte, Inc. CEO Laura E. Niklason · Market cap $119.0M.
$0.71
+0.09 · +14.29%
52w hi $2.8452w lo $0.55
Off 52w high 68.7%
60
NOTABLE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
1
0 strong · 1 notable
Analyst consensus
Strong Buy
Avg PT $3.00
Section 01
Recent Form 4 filings
5 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| May 19 | Kathleen Sebelius | Buy | 56,818 | $0.88 | +$50K | 60 | |
| Aug 19 | Brady W Dougan | Sell | 1,100,000 | $1.63 | −$1.79M | 35 | |
| Aug 19 | Laura E Niklason | President, CEO and Director | Sell | 1,100,000 | $1.63 | −$1.79M | 58 |
| Aug 18 | Laura E Niklason | President, CEO and Director | Sell | 549,360 | $1.83 | −$1.01M | 37 |
| Aug 18 | Brady W Dougan | Sell | 549,360 | $1.83 | −$1.01M | 28 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JulAugSepOctNovDecJanFebMarAprMayJun